Q3 FY2026
Filed Nov 5, 2026Kingsway Q3 2026 revenue rose 4.5% to $38.9 million; KSX revenue up 18.2% while consolidated net loss widened to $3.2 million
Segment growth is strong: KSX revenue rose 18.2% and KSX adjusted EBITDA rose 24.5% to $3.3 million, and Extended Warranty adjusted EBITDA rose 88.3% to $1.4 million. Against that, consolidated GAAP net loss widened to $3.2 million from $2.4 million, consolidated adjusted EBITDA was $2.0 million against $2.1 million a year earlier, and Extended Warranty revenue fell 9.8% as reported because Trinity was sold.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Consolidated revenue, three months ended 9/30/2026GAAP | $38.9M | – | +4.5% |
| KSX segment revenue, three months ended 9/30/2026GAAP | $22.4M | – | +18.2% |
| Extended Warranty segment revenue, three months ended 9/30/2026GAAP | $16.4M | – | -9.8% |
| Extended Warranty revenue excluding Trinity, three months ended 9/30/2026other | $16.4M | – | +5.9% |
| Consolidated GAAP net loss, three months ended 9/30/2026GAAP | −$3.15M | – | – |
| Consolidated GAAP net loss, twelve months ended 9/30/2026GAAP | −$6.84M | – | – |
| Consolidated adjusted EBITDA, three months ended 9/30/2026non-GAAP | $1.98M | – | – |
| Consolidated adjusted EBITDA, twelve months ended 9/30/2026non-GAAP | $12.29M | – | – |
| KSX adjusted EBITDA, three months ended 9/30/2026non-GAAP | $3.31M | – | +24.5% |
| KSX adjusted EBITDA, twelve months ended 9/30/2026non-GAAP | $13.55M | – | – |
| Extended Warranty adjusted EBITDA, three months ended 9/30/2026non-GAAP | $1.44M | – | +88.3% |
| Extended Warranty adjusted EBITDA, twelve months ended 9/30/2026non-GAAP | $4.02M | – | – |
| Extended Warranty adjusted EBITDA excluding Trinity, three months ended 9/30/2026non-GAAP | $1.4M | – | – |
| Lender-defined Modified Cash Adjusted EBITDA, three months ended 9/30/2026other | $2.7M | – | – |
| Organic segment revenue growth, three months ended 9/30/2026non-GAAP | 7.6% | – | – |
| Organic segment adjusted EBITDA growth, three months ended 9/30/2026non-GAAP | 54.1% | – | – |
| Effect of acquisitions and dispositions on revenue growth, three months ended 9/30/2026non-GAAP | 3.1 percentage points | – | – |
| Cash from Operations, three months ended 9/30/2026other | $4.1M | – | – |
| Total net debt, as of 9/30/2026other | $60.3M | – | – |
| Portfolio LTM EBITDA, twelve months ended 9/30/2026non-GAAP | $23 million to $24 million | – | – |
| Revenue re-deferrals at operating subsidiaries, three months ended 9/30/2026other | approximately $0.6 million | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Kingsway Search Xcelerator (KSX)Release reports KSX revenue of $22.4 million compared with $19.0 million, and KSX adjusted EBITDA of $3.3 million, up 24.5% from $2.7 million. The consolidated organic reconciliation deducts $2,026 thousand of revenue from businesses acquired that do not appear in both periods. | $22.4M | – | +18.2% |
| Extended WarrantyReported revenue decreased 9.8% from $18.2 million. The release also presents Extended Warranty revenue excluding the sale of Trinity Warranty Solutions LLC at $16.4 million versus $15.5 million, up 5.9%, and states that Extended Warranty cash sales excluding Trinity increased 6.3%. Extended Warranty adjusted EBITDA rose 88.3% to $1.4 million from $0.8 million. | $16.4M | – | -9.8% |
What drove it
- Revenue growth of 4.5% is shown with an effect of acquisitions and dispositions of 3.1 percentage points. The organic segment revenue growth presented by the company is 7.6%.
- The organic reconciliation shows Trinity revenue of $2,694 thousand and Trinity adjusted EBITDA of $412 thousand in the three months ended 9/30/2025, which the company removes as a disposed business.
- The reconciliation shows revenue of businesses acquired of $2,026 thousand in the three months ended 9/30/2026, deducted to reach organic revenue.
- The CEO states that approximately $0.6 million of revenue re-deferrals occurred at the operating subsidiaries during the quarter, and that these are non-cash accounting items.
- The CEO states that, normalizing for these re-deferrals, segment profitability in the quarter would have been broadly consistent with the strong second quarter result. This is the company's explanation.
- Non-GAAP adjustments in Q3 2026 include employee-related expenses of $544 thousand and other items of $843 thousand, against $726 thousand and $1,317 thousand respectively in Q3 2025.
- The Q2 2026 non-GAAP reconciliation includes a gain on sale of Trinity of $1,347 thousand, removed from adjusted EBITDA. Consolidated adjusted EBITDA for Q2 2026 is printed as $5,178 thousand.
- The company reports that Portfolio LTM EBITDA rose to a range of $23 million to $24 million, and the CEO says he remains confident in its trajectory in the fourth quarter and into 2027.
Concerns
- Consolidated GAAP net loss was $3.2 million compared with a net loss of $2.4 million a year earlier, and a $157 thousand net income in Q2 2026.
- Consolidated adjusted EBITDA was $2.0 million compared with $2.1 million a year earlier, and $5,178 thousand in Q2 2026, a sequential decline the release does not explain in dollar terms beyond the re-deferral comment.
- Extended Warranty revenue declined 9.8% as reported, and the growth figure of 5.9% excludes the sale of Trinity. The two bases differ and the release does not print the Trinity revenue removed from reported Q3 2026 revenue.
- The CEO quote gives organic segment revenue growth as 8%, while the reconciliation table prints 7.6%. The table figure is used in this read.
- Portfolio LTM EBITDA ($23 million to $24 million) is a management estimate that includes acquired businesses as if owned for the full twelve months and is not comparable with the consolidated twelve-month adjusted EBITDA of $12,295 thousand.
What to watch
- Whether Portfolio LTM EBITDA moves within or above the $23 million to $24 million range in the fourth quarter, as the CEO expects.
- Whether the approximately $0.6 million of revenue re-deferrals reverse in later periods, as the company's normalization implies.
- Continued quarterly disclosure of organic revenue and organic adjusted EBITDA growth, which the company says it will provide each quarter.
- Trend in consolidated GAAP net loss, which widened year over year, and in consolidated adjusted EBITDA, which declined slightly year over year.
- Extended Warranty revenue on a basis excluding Trinity, and the trend in Extended Warranty cash sales.
- Net debt trend from $62.4 million at 12/31/2025 to $60.3 million at 9/30/2026, and conversion of EBITDA into Cash from Operations.
- Deal pipeline and acquisition activity, which the CEO describes as highly active.
Balance sheet and cash flow
- Total net debt was $60.3 million as of September 30, 2026, compared with $62.4 million as of December 31, 2025.
- Cash from Operations reached $4.1 million in the third quarter, according to the CEO.
- Lender-defined Modified Cash Adjusted EBITDA was $2.7 million. The release states this measure is the basis for financial covenant calculations under the Company's credit agreement.
- The release does not print a cash balance, total debt tranches, total assets or total equity.
Analysis
Kingsway reported third quarter 2026 consolidated revenue of $38.9 million, up 4.5% from $37.2 million. The company's organic reconciliation attributes 3.1 percentage points of that growth to the effect of acquisitions and dispositions, and shows organic revenue growth of 7.6%. The growth is concentrated in KSX, where revenue rose 18.2% to $22.4 million from $19.0 million. Extended Warranty reported revenue fell 9.8% to $16.4 million from $18.2 million, a decline that the release presents alongside the sale of Trinity Warranty Solutions LLC. On a basis excluding Trinity, Extended Warranty revenue rose 5.9% to $16.4 million from $15.5 million, and Extended Warranty cash sales excluding Trinity rose 6.3%.
Profitability was mixed. Consolidated GAAP net loss widened to $3.2 million from $2.4 million a year earlier. Consolidated adjusted EBITDA, a non-GAAP measure, was $2.0 million against $2.1 million, or $1,984 thousand against $2,059 thousand in the reconciliation. Segment adjusted EBITDA moved in the opposite direction: KSX adjusted EBITDA rose 24.5% to $3.3 million, and Extended Warranty adjusted EBITDA rose 88.3% to $1.4 million. The consolidated figure is therefore below the sum of the segment improvements, and the release does not print the corporate-level lines that explain the gap. Sequentially, consolidated adjusted EBITDA fell from $5,178 thousand in Q2 2026. The CEO attributes approximately $0.6 million of revenue re-deferrals at the operating subsidiaries to non-cash accounting items and states that, normalizing for them, segment profitability would have been broadly consistent with the second quarter. This is the company's explanation and the release does not quantify the re-deferral effect in the reconciliation.
Cash and capital allocation data are limited. The CEO cites Cash from Operations of $4.1 million in the quarter and lender-defined Modified Cash Adjusted EBITDA of $2.7 million, which the company says is the basis for covenant calculations. Total net debt was $60.3 million at September 30, 2026, against $62.4 million at December 31, 2025, a comparison to year-end rather than to a year earlier. The release does not disclose share repurchases, dividends or a cash balance. Twelve-month figures show consolidated adjusted EBITDA of $12,295 thousand against $8,460 thousand, KSX adjusted EBITDA of $13,555 thousand against $8,905 thousand, and Extended Warranty adjusted EBITDA of $4,023 thousand against $4,582 thousand.
The company provides no income statement detail beyond the reconciliations, so gross margin, operating expense lines, EPS and taxes cannot be read from this filing. The company has no formal outlook in this release. Its forward-looking content is the CEO's statement that Portfolio LTM EBITDA of $23 million to $24 million is trending positively and that he is confident in its trajectory in the fourth quarter and into 2027. Portfolio LTM EBITDA is a management estimate that includes acquired businesses as if owned for the full period, so it is not directly comparable with the consolidated twelve-month adjusted EBITDA. The organic growth figures are disclosed for the first time in this release, so no prior-period organic series is available for trend comparison. The CEO quote rounds organic revenue growth to 8%, while the reconciliation prints 7.6%.
Management, verbatim
Kingsway delivered another exceptional result in the third quarter, with strong profitability, organic growth, and cash flow
JT Fitzgerald, President and CEO
Normalizing for these non-cash accounting items, profitability of the segments in the quarter would have been broadly consistent with Kingsway’s strong second quarter result.
JT Fitzgerald, President and CEO
Not in the filing
stated, not guessed- Cost of sales, gross profit and gross margin for any period.
- Operating expense lines (such as SG&A, D&A or restructuring) as reported on the income statement.
- GAAP consolidated operating income, interest expense and income tax expense.
- GAAP and non-GAAP diluted EPS.
- Cash balance, total assets and total equity as of 9/30/2026.
- Free cash flow and full operating cash flow figure (only Cash from Operations of $4.1 million is stated in the CEO commentary).
- Consolidated revenue for Q2 2026 (prior quarter), and KSX and Extended Warranty revenue for Q2 2026.
- Percentage change for consolidated GAAP net loss and consolidated adjusted EBITDA year over year.
- Dollar level of Extended Warranty cash sales (only the 6.3% growth rate is printed).
- Dollar amount of Trinity revenue removed from reported Q3 2026 consolidated revenue, beyond the Q3 2025 Trinity figures.
- Prior-period figure for Portfolio LTM EBITDA (only the current range $23 million to $24 million is printed).
- Guidance or outlook for Q4 2026 or full-year 2026; no previous outlook was provided.
- Capital returns (share repurchases, dividends) for the period.
- Organic series for prior periods (organic metrics are published for the first time in this release).
- Quantified effect of the approximately $0.6 million revenue re-deferrals on individual segments.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.